Micronized 17β-estradiol (E2) was used as oral replacement therapy in 369 patients with
Safety and efficacy of Estrace (micronized 17 beta-estradiol) 1986;31 (3 Suppl
1986;31(3 Suppl [ESTROGEN]):39-44
5 mg) or sublingually (1 mg, 0
Hazards not otherwise classified (HNOC) Not Applicable Other hazards Not available Precautionary Statements - Prevention PIP: Treatment of 20 women with a combined oral contraceptive (OC) containing 1 mg of micronized 17beta-estradiol and 150 mcg of desogestrel taken for 21 days achieved successful ovulation inhibition in all cases and there was a marked suppression of follicular activity
1993; 43 (9):966–973
The subjects were studied with and without grapefruit juice intake contai
The transdermal systems delivered either 0
Transdermal estradiol provided serum and urinary levels of estradiol conjugates typical of the early follicular phase of the premenopausal
150 mg desogestrel for 21 days followed by 0
Brand names: Estrace, Estradiol Patch, Climara, Estrogen Patches, Vivelle-Dot Drug class: estrogens
Product Info It contains 17-beta-estradiol, which is the most potent form of estrogen
" Clinical profile of a new hormone replacement therapy containing 2 mg 17 beta-estradiol and 10 mg dydrogesterone
Travica D
METHODS: Single doses of micronized 17 beta-estradiol were administered orally (1 mg, 0
Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause
It is primarily produced by the dominant ovarian follicle and the corpus luteum and is synthesized in-tracellularly through aromatase activity
A mean peak of circulating E2 concentrations more than 15-times the basal level